The Greek Version of Modified Baecke Questionnaire

May 17, 2021 updated by: Vasiliki Stefanouli, University of Thessaly

Validity and Reliability of the Greek Version of the Modified Baecke Questionnaire

The purpose of this study was to translate and investigate the validity and reliability of the modified Baecke Physical Activity Questionnaire (mBQ) in the Greek adult population.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The purpose of this study was to translate and investigate the validity and reliability of the modified Baecke Physical Activity Questionnaire (mBQ) in the Greek adult population. The cross-cultural adaptation of the mBQ was performed according to official guidelines.The reliability was determined by filling out the mBQ, two times, one week apart. For validation, the scores between the mBQ and the IPAQ were compared and the correlation between mBQ and VO2max and between mBQ and interview (METS) were assessed.

Study Type

Observational

Enrollment (Actual)

145

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 59 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Healthy

Description

Inclusion Criteria:

  1. age above 18
  2. Greek native speakers
  3. Greek inhabitants
  4. sufficient cognitive functioning.

Exclusion Criteria:

  1. poor health status,
  2. diagnosed with cardiovascular diseases
  3. cardiac pacemaker,
  4. medication that prevents exercise activity
  5. neurological disorders with effect on the lower body
  6. musculoskeletal disorders or injuries on the lower body in the last 3 months
  7. PAR-Q health risk assessment form

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Reliability Group
100 Healthy Adults
Other: observational

The reliability was determined (n=100) by filling out the mBQ, two times, one week apart (test-retest).

For validation (n=45), the scores between the modified Baecke Questionnaire and the International Physical Activity Questionnaire were compared and the correlation between the modified Baecke Questionnaire and VO2max(via Astrand-Rhyming Cycle Ergometer Test) and between mBQ and interview (via METS) were assessed.
Validity Group
45 Healthy Adults
Other: observational

The reliability was determined (n=100) by filling out the mBQ, two times, one week apart (test-retest).

For validation (n=45), the scores between the modified Baecke Questionnaire and the International Physical Activity Questionnaire were compared and the correlation between the modified Baecke Questionnaire and VO2max(via Astrand-Rhyming Cycle Ergometer Test) and between mBQ and interview (via METS) were assessed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reliability
Time Frame: one week apart

The reliability was determined by filling out the modified Baecke Questionnaire, two times, one week apart (test-Retest).

Tool: Modified Baecke Questionnaire (test-retest)
one week apart
Validity
Time Frame: 1) IPAQ ( Time Frame: 30 min) 2) Astrand-Rhyming Cycle Ergometer Test (Time Frame: 20 min) 3) Interview (Time Frame: 45 min) 4)Modified Baecke Questionnaire (Time Frame: 30 min)

For validation, the scores between the modified Baecke Questionnaire and the International Physical Activity Questionnaire (IPAQ) were compared and the correlation between Modified Baecke Questionnaire and VO2max (via Astrand-Rhyming Cycle Ergometer Test) and between modified Baecke Questionnaire and interview (via METS) were assessed.

Tools:

  1. International Physical Activity
  2. Astrand-Rhyming Cycle Ergometer Test Questionnaires (VO2max)
  3. Interview (METS)

2)
1) IPAQ ( Time Frame: 30 min) 2) Astrand-Rhyming Cycle Ergometer Test (Time Frame: 20 min) 3) Interview (Time Frame: 45 min) 4)Modified Baecke Questionnaire (Time Frame: 30 min)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Thessaly

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 1, 2015

Primary Completion (ACTUAL)

July 20, 2016

Study Completion (ACTUAL)

March 25, 2021

Study Registration Dates

First Submitted

April 22, 2021

First Submitted That Met QC Criteria

May 17, 2021

First Posted (ACTUAL)

May 18, 2021

Study Record Updates

Last Update Posted (ACTUAL)

May 18, 2021

Last Update Submitted That Met QC Criteria

May 17, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • cepr_lab

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

GDPR protected

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe